Search

Your search keyword '"Simader, Elisabeth"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Simader, Elisabeth" Remove constraint Author: "Simader, Elisabeth"
46 results on '"Simader, Elisabeth"'

Search Results

1. Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency: A prospective controlled open-label trial

2. FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study

5. Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

10. Pregnancy outcomes in patients with systemic lupus erythematosus compared to a high‐risk tertiary cohort and to standard population from the Austrian birth registry.

11. Bona fide dendritic cells are pivotal precursors for osteoclasts

13. Bona fide dendritic cells are pivotal precursors for osteoclasts.

16. The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination

18. Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions

20. Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis.

21. Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

22. Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

23. Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study

24. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial

25. Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.

26. Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis

27. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial

28. Fractional heat shock protein 27 urine excretion as a short-term predictor in acute exacerbation of chronic obstructive pulmonary disease

30. Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.

31. Heat shock protein 27 as a predictor of prognosis in patients admitted to hospital with acute COPD exacerbation

33. Topical application of apoptotic peripheral mononuclear blood cell secretome enhances epithelisation in genetically diabetic db/db mice

35. Non-classical monocytes as mediators of tissue destruction in arthritis

37. Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I)

38. Analysis of region specific gene expression patterns in the heart and systemic responses after experimental myocardial ischemia

39. Die westliche Finanzkrise : Islamic Financing – Islamic Banking- Ein moeglicher Ausweg?

40. Dying blood mononuclear cell secretome exerts antimicrobial activity

42. Increased serum concentrations of soluble ST2 are associated with pulmonary complications and mortality in polytraumatized patients.

43. Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration

Catalog

Books, media, physical & digital resources